Brain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE)
- Conditions
- REM Sleep Behavior DisorderHealthy
- Interventions
- Other: Clinical investigations
- Registration Number
- NCT03072940
- Lead Sponsor
- Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
- Brief Summary
Idiopathic rapid eye movement sleep behavior disorder (iRBD) is characterized by nocturnal violence, increased muscle tone during REM sleep and the lack of any other neurological disease. However, iRBD can precede parkinsonism and dementia by several years. The causes of the loss of muscle atonia during REM sleep in these patients are unclear. Using 3 T MRI and neuromelanin- sensitive sequences, the signal intensity was previously found to be reduce in the locus coeruleus/subcoeruleus area of patients with Parkinson's disease and RBD. Here, the investigators aimed at studying the integrity of the locus coeruleus/ subcoeruleus complex with neuromelanin-sensitive imaging in 21 patients with iRBD and compared the results with those from 21 age- and gender-matched healthy volunteers. All subjects will undergo a clinical examination, motor, cognitive, autonomous, psychological, olfactory and color vision tests, and rapid eye movement sleep characterization using video-polysomnography and 3 T magnetic resonance imaging.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
- idiopathic RBD (criteria of the international classification of sleep disorders-3)
For healthy controls : no neurologic or psychiatric disorder
- Contraindication to MRI
- Do not speak French
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Healthy volunteers Clinical investigations - Patients with idiopathic RBD Clinical investigations -
- Primary Outcome Measures
Name Time Method Signal in the subcoeruleus/coeruleus complex 24h Brain imaging signal in the subcoeruleus/coeruleus complex in 3T multimodal MRI, using neuromelanin-sensitive sequence
- Secondary Outcome Measures
Name Time Method Substantia nigra quantity 24h size of the substantia nigra
Quality of Sleep 24h Measures in videopolysomnography of efficiency of sleep
Cognition 24h Cognition status (MoCA test)
Olfactory function 24h Olfactory function (sniff test)
Color vision 24h Color vision function
Trial Locations
- Locations (1)
Pitie Salpetriere hospital
🇫🇷Paris, France